CClinicalTrials.gg
CompletedNCT05116553Updated Jan 21, 2022

Motivational Evaluation and Intervention With Co-Adapt Application for Healthy Ageing

An interventional study of SDT and APP + CA in Motivation and Self Efficacy, sponsored by Idego srl. Completed at 1 site in Italy. Open to participants aged 50 Years to 67 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-01-21.

Sponsored by Idego srl · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
74
Allocation
Randomized
Ages
50 Years to 67 Years
Sex
All
01

Study summary

The aim of this study is to identify effective methodologies to help people to improve their awareness of change, motivation, self-confidence and self-efficacy, compliance in behavioral change and psychological well-being.

Read the detailed description

Subjects involved will have the opportunity to partecipate in a two-weeks course: two SDT (Self Determination Theory) psychological interviews are scheduled (1 per week) to help the participant increase his motivation and awareness about the problem reported during the counseling session.

For this purpose, the use of an APP with a CA (Conversational Agent) will be implemented as a support to help people to identify one's thoughts and emotional states as well as increase their awareness about themselves.

Test will be administered at the beginning (T1) and at the end of the meetings (T2).

Participants will be randomly divided into one of two groups to understand whether APP and CA has a significant impact in increasing motivation and awareness of the need for a pathway with a professional.

02

Conditions studied

  • Motivation
  • Self Efficacy

Keywords

  • Motivation
  • Self efficacy
03

In context

Lead sponsor

Idego srl is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 67 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • whitecollar
  • a sufficient level of education to understand study procedures and be able to communicate with site personnel
  • 50 to 70 years old

Exclusion criteria

Exclusion Criteria:

  • current use of narcotics or other substances
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
74 participants (actual)

Study arms

  • Active comparator
    SDT (MI)

    This group will receive standard 2 SDT (Self Determination Theory) psychological interviews.

    Behavioral: SDT

  • Experimental
    SDT (MI) + CA

    This group will receive standard 2 SDT (Self Determination Theory) psychological interviews; moreover they will use an APP with a CA (Conversational Agent), an Artificial Intelligence.

    Behavioral: SDT · Device: APP + CA

Interventions

  • BehavioralSDT

    Standard 2 SDT (Self Determination Theory) psychological interviews.

  • DeviceAPP + CA

    An APP with a CA (Conversational Agent).

06

What researchers measure

Primary outcomes

  1. Change in levels of General Self-Efficacy Scale-10 (GSE-10)

    GSE-10 test is a validated test for the detection of general self efficacy. The total score ranges from 10 to 40. Higher scores mean better outcomes.

    Time frame: Up to day 14

  2. Change in levels of Basic Psychological Need Satisfaction and Frustration Scale (BPNSFS)

    The BPNSFP-24 test is a validated test for the detection of the satisfaction and frustration of the primary needs: autonomy, relatedness and competence (according to SDT Theory). The total score ranges from 24 to 120. Higher scores mean better outcomes.

    Time frame: Up to day 14

Secondary outcomes

  1. Change of the scales contained in the Depression Anxiety Stress Scales-21 (DASS-21)

    The DASS-21 test is a validated test for the detection of depression, anxiety and stress. The total score of each subscale ranges from 0 to 42. Higher scores mean worse outcomes.

    Time frame: Up to day 14

  2. Change in World Health Organisation-Five Well-Being Index (WHO-5)

    The WHO-5 test is a validated test for the detection of psychological wellbeing. The total score ranges from 0 to 100. Higher scores mean better outcomes.

    Time frame: Up to day 14

07

Study locations

1 site
  • Idego srl
    Rome, 00197, Italy
08

References and documents

Individual participant data

Plan to share: Yes — Clinical data obtained from psychological testing and socio-demographic data and any feedback collected during the trial will be shared.

Supporting information: Study protocol, Sap

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 21, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05116553
Lead sponsor
Idego srl
Responsible party
Sponsor
First posted
Nov 11, 2021
Start date
Nov 11, 2021
Primary completion
Dec 31, 2021
Completion
Jan 20, 2022
Last update
Jan 21, 2022

Study contacts

Tommaso Ciulli
principal investigator · Idego srl

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion